PAVmed Inc. (PAVM)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 350K 700K 1.1M Q3 '24: 996K Q4 '24: 10K Q1 '25: 8K Q2 '25: 6K Q3 '25: 5K Q4 '25: 52K Q1 '26: 22K Q2 '26: 33K Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Gross Profit Quarterly

-210K -140K -70K 0 70K 140K 210K Q3 '21: 56K Q4 '21: -141K Q1 '22: -180K Q2 '22: 0 Q3 '21 Q4 '21 Q1 '22 Q2 '22

Operating Income Quarterly

-12M -8M -4M 0 4M 8M 12M Q3 '24: -11.6M Q4 '24: -5.2M Q1 '25: -5.4M Q2 '25: -4.7M Q3 '25: -4.8M Q4 '25: -6.8M Q1 '26: -8M Q2 '26: -7M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Net Income Quarterly

-25M 0 25M 50M 75M Q3 '24: 64.4M Q4 '24: 1.4M Q1 '25: 19M Q2 '25: -11.9M Q3 '25: -5.4M Q4 '25: -1.3M Q1 '26: -60K Q2 '26: -5.4M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Cost of Revenue Quarterly

0 500K 1M 1.5M Q3 '24: 1.4M Q4 '24: 48K Q1 '25: 36K Q2 '25: 41K Q3 '25: 55K Q4 '25: 85K Q1 '26: 97K Q2 '26: 122K Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating Cash Flow Quarterly

-10.5M -7M -3.5M 0 3.5M 7M 10.5M Q3 '24: -8.9M Q4 '24: 94K Q1 '25: -1.6M Q2 '25: -1.2M Q3 '25: -896K Q4 '25: -1.6M Q1 '26: -2.6M Q2 '26: -2.7M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Free Cash Flow Quarterly

-10.5M -7M -3.5M 0 3.5M 7M 10.5M Q3 '24: -8.9M Q4 '24: 90K Q1 '25: -1.6M Q2 '25: -1.2M Q3 '25: -899K Q4 '25: -1.6M Q1 '26: -2.6M Q2 '26: -2.7M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 20M 40M 60M Q1 '24: 8.7M Q2 '24: 9.2M Q3 '24: 44.5M Q1 '25: 1.7M Q2 '25: 602.8K Q3 '25: 21.6M Q1 '26: 1.6M Q2 '26: 6.3M Q1 '24 Q2 '24 Q3 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-18.00 -9.00 0.00 9.00 18.00 27.00 Q1 '24: -9.03 Q2 '24: -8.12 Q3 '24: -4.30 Q4 '24: 11.74 Q1 '25: 24.46 Q2 '25: 3.57 Q3 '25: 1.84 Q4 '25: -5.63 Q1 '24 Q2 '24 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.